“Our goal is to harness the power of gene therapy to improve patient lives globally,” Jude Samulski, co-founder and current board member of AskBio states while sharing his insights on the future of #genetherapy in a recently published article in Nature. This article shines a light on AskBio’s pioneering spirit and unwavering commitment to forging a new path where gene therapy can transform countless lives. At #AskBio, we are on the forefront of innovation, dedicated to advancing research and embracing cutting-edge science to revolutionize the field of gene therapy and make strides for a brighter future for all. Read the article (accessible with a subscription) and let us know what you think. https://lnkd.in/efQHZcmj
Asklepios BioPharmaceutical, Inc. (AskBio)’s Post
More Relevant Posts
-
Gene therapy is revolutionizing the future of medicine, offering new possibilities for treating a range of genetic disorders. At Genflow Biosciences (LON:GENF) (OTCQB:GENFF), we are at the front of this groundbreaking field, using the power of genetic engineering to enhance human health and longevity. Our latest advancements in gene therapy have been on the #SIRT6 gene, known for its role in extending #healthspans and treating age-related diseases. By leveraging the power of #SIRT6, we aim to provide solutions for a healthier, longer life. Key highlights of Genflow’s gene therapy program include: ✅ Cutting-Edge Research: Using latest technologies to advance the application of gene therapy. ✅ Transformative Impact: Offering potential cures for previously untreatable genetic conditions. #Gene #GENF #invest
To view or add a comment, sign in
-
Join Dipika Gurnani for an in-depth discussion on cell and gene therapy safety and purity testing, the challenges involved for manufacturers and how the latest innovations in ddPCR technology can help you: - Test for Replication Competent Virus (RCV) - Bring your gene therapies to market faster #RCV #ddPCR #purity
New Webinar! Time to Upgrade: Boosting Speed and Safety in Gene Therapy Quality Assurance Join Dipika Gurnani for an in-depth discussion on cell and gene therapy safety and purity testing, the challenges involved for manufacturers and how the latest innovations in ddPCR technology can help you: - Test for Replication Competent Virus (RCV) - Bring your gene therapies to market faster Mark the date: December 12, 2023 11:00 AM EST | 8:00 AM PST Register now for this informative webinar: https://ow.ly/v57m50QbPzM #genetherapy #ddPCR #innovation #qualityassurance #viralQC
Time to Upgrade: Boosting Speed and Safety in Gene...
themedicinemaker.videomarketingplatform.co
To view or add a comment, sign in
-
Was a fascinating Ad Com yesterday @FDA for the first-ever therapy to use CRISPR/Cas9 gene editing (Vertex's very impressive exa-cel gene therapy for sickle cell disease)- "Off target" gene editing, genomic heterogeneity, genome sequencing of edits, and the long term biological consequences of undesired edits was up for discussion. Take homes are its really important to analyse the genetic changes after editing and to hold samples back for long-term follow up (maybe a new guidance coming soon). The potential approval of this product next month is an important step for the CRISPR/Cas9 gene editing field of which there are dozens of other therapies in development.
To view or add a comment, sign in
-
Droplet digital PCR (ddPCR) is quickly becoming a mainstay of gene therapy. But scientists are struggling with data handling. Discover how the Tetra Scientific Data and AI Cloud™ streamlines ddPCR workflows, improving scientific outcomes in gene therapy. https://lnkd.in/ep9NFZTC #genetherapy #ddPCR #ScientificDataAndAICloud #ScientificOutcomes
ddPCR in gene therapy: Solving data workflow challenges
tetrascience.com
To view or add a comment, sign in
-
Droplet digital PCR (ddPCR) is quickly becoming a mainstay of gene therapy. But scientists are struggling with data handling. Discover how the Tetra Scientific Data and AI Cloud™ streamlines ddPCR workflows, improving scientific outcomes in gene therapy. https://lnkd.in/gzWS6W3E #genetherapy #ddPCR #ScientificDataAndAICloud #ScientificOutcomes
ddPCR in gene therapy: Solving data workflow challenges
tetrascience.com
To view or add a comment, sign in
-
We are proud to be recognised in the BioIndustry Association (BIA) Cell and Gene Therapy report, which outlines the UK’s pivotal role in advancing life-changing cell and gene therapy research to deliver transformative outcomes for patients living with debilitating or life-shortening conditions. To date, there has been a lack of innovation in treatment options for chronic kidney disease, despite a patient population of over 840 million people worldwide. Purespring’s novel gene therapy platform, which delivers a disease-modifying gene directly to the podocyte, has the potential to make a real difference to the lives of patients around the world. For more information on the UK’s thriving #CellandGeneTherapy ecosystem, read the full report here: https://lnkd.in/dZJ_4H4Y #GeneTherapy #CellandGeneUK #Biotech #KidneyDiseases
To view or add a comment, sign in
-
SCIEX Webinar: how LC-MS and CE Technology can help in Cell & Gene Therapy Analysis
📣 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 𝗔𝗹𝗲𝗿𝘁: 𝗖𝗲𝗹𝗹 𝗮𝗻𝗱 𝗴𝗲𝗻𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝘂𝘀𝗶𝗻𝗴 𝗟𝗖-𝗠𝗦 𝗮𝗻𝗱 𝗖𝗘 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 Join our experts in this webinar as they share how SCIEX Liquid chromatography–mass spectrometry (LC–MS) and capillary electrophoresis (CE) technologies can aid cell and gene therapy analysis. Learn from these insightful sessions: 𝗖𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗼𝗹𝗶𝗴𝗼𝗻𝘂𝗰𝗹𝗲𝗼𝘁𝗶𝗱𝗲𝘀 𝗮𝗻𝗱 𝗴𝗲𝗻𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝘀 𝘂𝘀𝗶𝗻𝗴 𝗟𝗖-𝗠𝗦 Speaker: Do-Young Choi, Senior Field Application & Market Development Specialist, SCIEX Korea 𝗔 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗰𝗲𝗹𝗹 𝗮𝗻𝗱 𝗴𝗲𝗻𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝘄𝗶𝘁𝗵 𝗵𝗶𝗴𝗵-𝗿𝗲𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗖𝗘 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 Speaker: Ye-Ji Kim, Field Application & Market Development Specialist, SCIEX Korea Sign up now👉 https://sciex.li/811s8c #SCIEXKosea #CapillaryElectrophoresis #GeneTherapy
To view or add a comment, sign in
-
Neuroscientist | Viral vectors | AAV | Gene Therapy | CMC | Preclinical R&D | Ocular Gene Therapy | Advanced Therapies | Rare Diseases
Thrilled to share my recent interview with Abigail Pinchbeck from Cell and Gene Therapy Insights! 🎙️ Discussed the exciting yet challenging journey of developing viral vector-based cell and gene therapy drug products. Shared insights on the hurdles I've faced, but there's still so much more to overcome for the approval of these groundbreaking therapies. #CellTherapy #GeneTherapy #InnovationInHealthcare" #cellandgenetherapy #viralvectors #AAV #drugdevelopment https://lnkd.in/gqtrmRV6
Current limitations & potential innovations in developing IND-enabling rAAV- & lentivirus-based gene therapy drug products
insights.bio
To view or add a comment, sign in
-
🔬 Discover the Comprehensive AAV Gene Therapy Characterization Report Explore our Characterization Report, offering a thorough analysis of an adeno-associated virus (AAV) gene therapy product. Using advanced sequencing techniques, it covers read alignments, sequence variants, and contamination levels to provide a detailed genetic composition overview. Learn how this report provides critical insights into the quality, safety, and manufacturability of cell and gene therapy products. It’s essential reading for professionals in gene therapy research, development, and quality control. Explore the full report below. #GeneTherapy #AAV #Biotechnology
To view or add a comment, sign in
36,004 followers
Chief Growth Officer at Scrupp | Driving Sales Growth, Analytics Expert
1moExciting advancements in gene therapy!